New drug shows promise for Post-Surgery sugar crashes
NCT ID NCT05721729
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called mizagliflozin in 15 people who had gastric bypass surgery and suffer from dangerously low blood sugar after eating. The goal was to see if the drug could reduce these episodes and improve safety. The trial is now complete, and results will help determine if this treatment can better control this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTBARIATRIC HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford
Palo Alto, California, 94304, United States
-
University of Colorado / Anschutz Medical Campus
Aurora, Colorado, 80045, United States